Windtree Therapeutics INC /DE/ DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OTC.Pink
Windtree Therapeutics seeks shareholder approval for significant capital raises, a reverse stock split, and increased authorized shares to support operations and maintain Nasdaq listing.
OTC.Pink
Windtree Therapeutics is asking stockholders to approve a reverse stock split and an increase in the number of shares available under its equity incentive plan at a special meeting on February 3, 2025.
OTC.Pink
DEF 14A: Windtree Therapeutics Seeks Stockholder Approval for Key Proposals at Upcoming Annual Meeting
Windtree Therapeutics is holding its 2024 Annual Meeting of Stockholders virtually on September 24, 2024, to vote on director elections, executive compensation, auditor ratification, and approval of common stock issuances related to financing agreements.
OTC.Pink
DEF 14A: Windtree Therapeutics Seeks Stockholder Approval for Reverse Stock Split to Regain Nasdaq Compliance
Windtree Therapeutics is asking stockholders to approve a reverse stock split to increase its stock price and meet Nasdaq's continued listing requirements.